Items tagged with Drug-resistant TB
FDA Antimicrobial Drugs Advisory Committee recommends approval of pretomanid (post with simple image)
Investigational drug pretomanid is under regulatory review by FDA for treatment of XDR-TB and treatment-intolerant or non-responsive MDR-TB as part of a new investigational regimen.
Activists demand Johnson & Johnson drop the price of bedaquiline (post with simple image)
Activists storm the corporate stall of Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson) at the 9th South African AIDS Conference.
Transparency and access to pretomanid and the Nix-TB regimen (post with simple image)
Advocates request responsible investment in pretomanid promoting transparency and equitable access.
Public call for individual patient data on treatment of drug-resistant TB (post with simple image)
The World Health Organization issues a public call for individual patients data on rifampicin-resistant and multidrug-resistant TB treatment outcomes.
Update of WHO guidelines on the programmatic management of drug-resistant TB (post with simple image)
End-users (i.e. policy makers; health professionals, including doctors, nurses and educators working in governmental and non-governmental organizations; TB patients) interested in providing comments on the scope of this guideline update are invited to submit their feedback.
FDA approves pretomanid for highly drug-resistant forms of TB (post with simple image)
Pretomanid receives FDA approval in combination regimen with bedaquiline and linezolid for people with XDR-TB or treatment-intolerant/non-responsive MDR-TB.
Practice-based recommendations for the management of RR/MDR-TB (post with simple image)
Statement from DR-TB STAT and TAG outlining practice-based recommendations for the optimal management of RR/MDR-TB.
MSF technical brief: Making the switch (post with simple image)
Saving more lives with optimal treatment for drug-resistant TB.
TB drug delamanid must be more affordable and made available in more countries (post with simple image)
Médecins Sans Frontières acknowledges the lower price offered to the government of South Africa for delamanid, but calls for it to be significantly lower and expanded to all countries in need.
Global campaign launched urging Johnson & Johnson to reduce price of bedaquiline (post with simple image)
Médecins Sans Frontières launches a global campaign calling on Johnson & Johnson to lower the price of bedaquiline to no more than US$1 per day.
Page 86 of 86 · Total posts: 0←First 85 86